Metaplastic Tuft Cells in Pancreatic Cancer

胰腺癌中的化生簇细胞

基本信息

  • 批准号:
    10581696
  • 负责人:
  • 金额:
    $ 46.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-09 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Abstract Pancreatic ductal adenocarcinoma (PDA) is the 3rd most common cause of cancer-related death in the United States. This dismal outcome is in part due to the lack of understanding of the unique pathology of PDA that includes pronounced epithelial plasticity and evolution of an extensive reactive fibroinflammatory stroma. We have discovered an unusual cell type within preneoplasia and neoplasia known as the metaplastic tuft cell (MTC), which has been proposed to act as both a tumor initiating cell and as a chemosensory cell that drives the fibroinflammatory host response. Normal tuft cells are found in normal glandular tissues and are marked by the expression of the microtubule kinase DCLK1. There they sample the luminal environment and respond to signals by modifying the Type 2 immune response. While there are no tuft cells found in the normal pancreas, they arise in a transdifferentiation event to become part of the metaplastic and neoplastic epithelium during oncogenesis or tissue injury. Besides their chemosensory function, they have been hypothesized to be a tumor initiating progenitor cell. In order to definitively determine the origins and functions of the metaplastic tuft cell, we have created a dual recombinase driven mouse model of pancreatic neoplasia combined with an inducible Cre recombinase that specifically targets MTCs that will allow us to alternatively trace and target the metaplastic tuft cells independent of neoplastic transformation in vivo. We have also devised human and mouse organoid culture systems that preserve tuft cell differentiation, so that we can study their genesis, fate and chemosensory function in more detail. Together, these tools will be used to rigorously determine the function of the metaplastic tuft cell and whether manipulating their functions can be used to treat pancreatic cancer.
摘要 胰腺导管腺癌(PDA)是第三大最常见的癌症相关原因。 死亡在美国。这种令人沮丧的结果部分是由于缺乏对 PDA的独特病理学包括显著的上皮可塑性和 广泛的反应性纤维炎性间质。我们发现了一种不寻常的细胞类型 肿瘤前病变和肿瘤称为化生簇细胞(MTC),已提出 作为肿瘤起始细胞和化学感受细胞, 纤维炎性宿主反应。正常簇细胞存在于正常腺体组织中,并且 以微管激酶DCLK1的表达为标志。在那里,他们采集了 通过改变2型免疫反应来改变环境并响应信号。虽然有 在正常胰腺中没有发现簇状细胞,它们在转分化事件中出现, 在肿瘤发生或组织损伤过程中的部分化生和肿瘤上皮。除了 由于它们的化学感受功能,它们被假设为肿瘤起始祖细胞, cell.为了明确化生簇细胞的起源和功能,我们 已经建立了一种双重重组酶驱动的胰腺肿瘤小鼠模型, 一种特异性靶向MTCs的诱导型Cre重组酶, 在体内追踪和靶向不依赖于肿瘤转化的化生簇细胞。我们 还设计了人类和小鼠类器官培养系统, 分化,以便我们可以研究它们的起源,命运和化学感受功能, 详细总之,这些工具将被用来严格确定化生的功能, 簇状细胞以及操纵它们的功能是否可用于治疗胰腺癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Howard C Crawford其他文献

Howard C Crawford的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Howard C Crawford', 18)}}的其他基金

Fibroblast orchestration of the immune response in pancreatic cancer
胰腺癌免疫反应的成纤维细胞协调
  • 批准号:
    10516238
  • 财政年份:
    2022
  • 资助金额:
    $ 46.5万
  • 项目类别:
Fibroblast orchestration of the immune response in pancreatic cancer
胰腺癌免疫反应的成纤维细胞协调
  • 批准号:
    10706561
  • 财政年份:
    2022
  • 资助金额:
    $ 46.5万
  • 项目类别:
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
中断胰腺癌免疫抑制微环境中的细胞串扰
  • 批准号:
    9449550
  • 财政年份:
    2017
  • 资助金额:
    $ 46.5万
  • 项目类别:
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
中断胰腺癌免疫抑制微环境中的细胞串扰
  • 批准号:
    10267780
  • 财政年份:
    2017
  • 资助金额:
    $ 46.5万
  • 项目类别:
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
中断胰腺癌免疫抑制微环境中的细胞串扰
  • 批准号:
    10242453
  • 财政年份:
    2017
  • 资助金额:
    $ 46.5万
  • 项目类别:
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia
盘状结构域受体:胰腺炎和胰腺癌前期的新参与者
  • 批准号:
    8811574
  • 财政年份:
    2014
  • 资助金额:
    $ 46.5万
  • 项目类别:
ADAM17 in pancreatic cancer and pancreatitis
ADAM17 在胰腺癌和胰腺炎中的作用
  • 批准号:
    8815948
  • 财政年份:
    2012
  • 资助金额:
    $ 46.5万
  • 项目类别:
ADAM17 in pancreatic cancer and pancreatitis
ADAM17 在胰腺癌和胰腺炎中的作用
  • 批准号:
    8608499
  • 财政年份:
    2012
  • 资助金额:
    $ 46.5万
  • 项目类别:
ADAM17 in pancreatic cancer and pancreatitis
ADAM17 在胰腺癌和胰腺炎中的作用
  • 批准号:
    8450710
  • 财政年份:
    2012
  • 资助金额:
    $ 46.5万
  • 项目类别:
ADAM17 in pancreatic cancer and pancreatitis
ADAM17 在胰腺癌和胰腺炎中的作用
  • 批准号:
    8236859
  • 财政年份:
    2012
  • 资助金额:
    $ 46.5万
  • 项目类别:

相似海外基金

SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
  • 批准号:
    2307983
  • 财政年份:
    2023
  • 资助金额:
    $ 46.5万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了